Estrogen modulation of osteoclast lysosomal enzyme secretion
- 19 February 1995
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 57 (2) , 271-279
- https://doi.org/10.1002/jcb.240570211
Abstract
Osteoclast‐mediated bone resorption is accomplished by secretion of lysosomal proteases into an acidic extracellular compartment. We have previously demonstrated that avian osteoclasts and human osteoclast‐like giant cell tumor cells respond in vitro to treatment with 17β‐estradiol (17β‐E2) by decreased bone resorption activity. To better understand the mechanism by which this is accomplished, we have investigated the effects of 17β‐E2 treatment on lysosomal enzyme production and secretion by isolated avian osteoclasts and multinucleated cells from human giant cell tumors in vitro. Isolated cells were cultured with bone particles in the presence of either vehicle or steroid. The conditioned media and cells were harvested, and the levels of cathepsin B, cathepsin L, β‐glucuronidase, lysozyme, and tartrate‐resistant acid phosphatase (TRAP) activities were determined. There was a steroid dose‐dependent decrease in secreted levels of these enzymes. Cell‐associated levels of cathepsin L, β‐glucuronidase, and lysozyme decreased, whereas cell‐associated levels of cathepsin B and TRAP increased. These changes were measurable at 10−10 M and maximal at 10−8 M 17β‐E2. The changes were detectable at 4–18 h of treatment and increased through 24 h of treatment. The response was steroid specific, since the inactive estrogen isomer, 17β‐E2, failed to alter the activity levels. Moreover, the effects of 17β‐E2 were blocked when the cells were treated simultaneously with the estrogen antagonist ICI182–780 in conjunction with 17β‐E2. Human osteoclast‐like cells obtained from giant cell tumors of bone responded similarly to estrogen with respect to cathepsin B, cathepsin L, and TRAP activities. However, secretion of β‐glucuronidase and lysozyme were not altered by treatment with 10−8 M 17β‐E2. These data indicate that estrogen effects on osteoclast resorption activity may be mediated by decreasing the secretion of cathepsin B, cathepsin L, and TRAP.Keywords
This publication has 29 references indexed in Scilit:
- Transforming growth factor alpha and CD68 immunoreactivity in giant cell tumours of bone: A study on the nature of stromal and giant cells, and their interrelationsThe Journal of Pathology, 1993
- Participation of cathepsin L on bone resorptionFEBS Letters, 1993
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclastsJournal of Bone and Mineral Research, 1991
- Cathepsin B and L activities in isolated osteoclastsBiochemical and Biophysical Research Communications, 1991
- Inhibition of osteoclastic acid phosphatase abolishes bone resorptionBiochemical and Biophysical Research Communications, 1989
- Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway.The Journal of cell biology, 1988
- Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts*1Experimental Cell Research, 1988
- Eine spektrophotometrische Bestimmungsmethode für saure und alkalische PhosphatasenHelvetica Chimica Acta, 1953
- The measurement of lysozyme activity and the ultra-violet inactivation of lysozymeBiochimica et Biophysica Acta, 1952